SCHEMBL55966

SCHEMBL55966

CCC#CCCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223277 0.97 PTPN7 (0.54)
SCHEMBL9015928 0.97 PTPN7 (0.54)
SCHEMBL6467458 0.97 PTPN7 (0.54)
SCHEMBL55675 0.97 PTPN7 (0.54)
SCHEMBL9015846 0.97 PTPN7 (0.54)
SCHEMBL9015963 0.97 PTPN7 (0.54)
SCHEMBL161365 0.97 PTPN7 (0.54)
SCHEMBL4224620 0.97 PTPN7 (0.54)
SCHEMBL6468299 0.97 PTPN7 (0.54)
SCHEMBL4212914 0.97 PTPN7 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
CN-117250354-B Application of detection reagent for eleven metabolic markers in preparation of breast cancer diagnosis and prognosis products 西安交通大学医学院第一附属医院 2024-05-10 CN claimed
WO-2024073678-A2 PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE OMEGA THERAPEUTICS, INC. (US) 2024-04-04 WO claimed
CN-117147845-B Application of detection reagent of metabolic marker 3-nonyne in preparation of breast cancer screening and prognosis products 西安交通大学医学院第一附属医院 2024-03-01 CN claimed
CN-117250354-A Application of detection reagent for eleven metabolic markers in preparation of breast cancer diagnosis and prognosis products 西安交通大学医学院第一附属医院 2023-12-19 CN claimed
CN-117147845-A Application of detection reagent of metabolic marker 3-nonyne in preparation of breast cancer screening and prognosis products 西安交通大学医学院第一附属医院 2023-12-01 CN claimed
WO-2023225621-A2 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS OMEGA THERAPEUTICS, INC. (US) 2023-11-23 WO claimed
US-9568821-B2 Patterning process SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-02-14 US claimed
US-9507262-B2 Resist top-coat composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-29 US claimed
US-20150234278-A1 PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-08-20 US claimed
US-20150234274-A1 RESIST TOP-COAT COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-08-20 US claimed
JP-58223409-A None JP disclosed
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US disclosed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
EP-0232776-A2 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1987-08-19 EP disclosed
US-4590319-A USING AS CATALYST A COBALT COMPOUND, ORGANOPHOSPHINE COMPOUND, AND ALUMINUM COMPOUND MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1986-05-20 US disclosed
EP-0155551-A1 Method for the partial hydrogenation of conjugated dienes MITSUBISHI KASEI CORPORATION (JP) 1985-09-25 EP disclosed
JP-S58223409-A GAS SEPARATION FILM SANYO CHEM IND LTD 1983-12-26 JP disclosed